Cell‐based therapy to reduce mortality from COVID‐19: Systematic review and meta‐analysis of human studies on acute respiratory distress syndrome

Cell‐based therapy to reduce mortality from COVID‐19: Systematic review and meta‐analysis of human studies on acute respiratory distress syndrome

Abstract Severe cases of COVID‐19 infection, often leading to death, have been associated with variants of acute respiratory distress syndrome (ARDS). Cell therapy with mesenchymal stromal cells (MSCs) is a potential treatment for COVID‐19 ARDS based on preclinical and clinical studies supporting th...

Full description

Bibliographic Details
Main Authors: Wenchun Qu, Zhen Wang, Joshua M. Hare, Guojun Bu, Jorge M. Mallea, Jorge M. Pascual, Arnold I. Caplan, Joanne Kurtzberg, Abba C. Zubair, Eva Kubrova, Erica Engelberg‐Cook, Tarek Nayfeh, Vishal P. Shah, James C. Hill, Michael E. Wolf, Larry J. Prokop, M. Hassan Murad, Fred P. Sanfilippo
Format: Article
Language:English
Published: Wiley 2020-09-01
Series:Stem Cells Translational Medicine
Subjects:
acute respiratory distress syndrome
COVID‐19
mesenchymal stromal cells
mortality
systematic review
Online Access:https://doi.org/10.1002/sctm.20-0146

Internet

https://doi.org/10.1002/sctm.20-0146

Similar Items